EPO Patents = 19 (Patent Applications = 4)

Average Co-Inventor Count = 7.1

ph-index = 5

Forward Citations = 115(Granted Patents)

Location History:

Idstein, DE (2003 - 2008)
Seiters, DE (2010)
Selters, DE (2006 - 2014)
Frankfurt-am-Main, DE (2009 - 2015)

Company Filing History:

17 out of 1,829

Sanofi-a Ventis Deutschland Gmbh

Aventis Pharma Deutschland, Gmbh

Aventis Pharmaceuticals Inc.

patents

where one patent can have more than one assignee

Years Active: 2003-2015

Loading Chart...

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8946212 - Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2015-02-03),

2. 8716317 - Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2014-05-06),

3. 8344004 - Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals (2013-01-01),

4. 8329725 - Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2012-12-11),

5. 8173674 - Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals (2012-05-08),

6. 8048901 - 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals (2011-11-01),

7. 7956077 - 2-{-3,'2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes (2011-06-07),

8. 7910612 - 4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use (2011-03-22),

9. 7872034 - Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals (2011-01-18),

10. 7872032 - 1, 3, 4-oxadiazol-2-ones as PPAR delta modulators and their use thereof (2011-01-18),

11. 7858647 - N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions thereof and methods for their therapeutic use (2010-12-28),

12. 7851493 - Phenyl-1,2,4-oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals (2010-12-14),

13. 7834030 - Phenyl-[1,2,4]-oxadiazol-5-one derivatives, pharmaceutical compositions and therapeutic use thereof (2010-11-16),

14. 7772257 - Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use (2010-08-10),

15. 7732471 - 6-oxazol-4-ylmetholmethoxy-alko-alkoxymethyl substituted benzoic acid derivatives forming peroxisome proliferator—activated receptor (PPAR) ligands, process for their preparation and methods of use thereof (2010-06-08),

Title: Wolfgang Wendler - Innovative Inventor from Selters

Introduction: Wolfgang Wendler is a renowned inventor hailing from Selters, Germany, known for his groundbreaking contributions to various fields.

Latest Patents: Wolfgang Wendler holds several patents in the areas of renewable energy technologies, sustainable agriculture, and advanced materials science.

Career Highlights: With a career spanning over three decades, Wolfgang Wendler has worked with leading research institutions and universities to develop cutting-edge solutions for global challenges.

Collaborations: Throughout his career, Wolfgang Wendler has collaborated with top companies in the industry, fostering innovation and driving progress in his respective fields.

Conclusion: Wolfgang Wendler's passion for innovation and his dedication to creating a positive impact on society through his inventions make him a true pioneer in the world of technology and science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

19 patents (EPO):

Please report any incorrect information to support@idiyas.com

4 patents pending (EPO):

Please report any incorrect information to support@idiyas.com